Lexicon Pharmaceuticals
LXRX
$1.57
Share price
-0.63%
Change (1 day)
-34.31%
Change (1 year)
Categories
EPS for Lexicon Pharmaceuticals (LXRX)
EPS in 2023 (TTM): -$0.68
According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.68. In 2022 the company made an earnings per share (EPS) of -$0.61 an increase over its 2021 EPS that were of -$0.61.
EPS history for Lexicon Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.68 | 11.48% |
| 2022 | -$0.61 | -0% |
| 2021 | -$0.61 | 10.91% |
| 2020 | -$0.55 | -145.08% |
| 2019 | $1.22 | -206.09% |
| 2018 | -$1.15 | -5.74% |
| 2017 | -$1.22 | -10.95% |
| 2016 | -$1.37 | 2640% |
| 2015 | -$0.05000 | -96.34% |
| 2014 | -$1.36 | -2.53% |
| 2013 | -$1.40 | -9.09% |
| 2012 | -$1.54 | -37.14% |
| 2011 | -$2.45 | 0% |
| 2010 | -$2.45 | -39.66% |
| 2009 | -$4.06 | 3.57% |
| 2008 | -$3.92 | -8.2% |
| 2007 | -$4.27 | -24.69% |
| 2006 | -$5.67 | 42.11% |
| 2005 | -$3.99 | -22.97% |
| 2004 | -$5.18 | -35.09% |
| 2003 | -$7.98 | -0% |
| 2002 | -$7.98 | 62.86% |
| 2001 | -$4.90 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $15.34 | -2,355.88% | 🇺🇸 USA |
 Illumina ILMN | -$26.61 | 3,813.24% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $37.36 | -5,594.12% | 🇺🇸 USA |
 Ultragenyx RARE | -$10.24 | 1,405.88% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.57 | -330.88% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$2.82 | 314.71% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -$0.75 | 10.29% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -214.51% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$5.64 | 729.41% | 🇺🇸 USA |